Active

Manipal Health Enterprises Limited

Manipal Health Enterprises Limited IPO Details

Listing Date

-

Bid Price

₹0 - ₹0

Lot Size

0 Shares

Minimum Investment

Issue Size

₹0 Cr

Key Dates to Track

    Here are the important dates you need to know in order to participate in this IPO

tick

Offer Start Date

-

tick

Offer End Date

-

tick

Allotment Date

-

tick

Refund Initiation

-

tick

Demat Transfer

-

tick

Listing Date

-

Manipal Health Enterprises Limited Shareholding Pattern

  Pre-Issue Post-Issue
Promoter Group 0% 0%
Public Group 100% 100%

Manipal Health Enterprises Limited IPO Reservation

QIB Shares Offered 0 (0%)
NII (HNI) Shares Offered 0 (0%)
Retail Shares Offered 0 (0%)
Anchor Investor Shares Offered 0 (0%)
Total Shares Offered 0
Total Shares With Anchor Investor 0

Manipal Health Enterprises Limited IPO Lot Size

Application Lots Shares Amount
Retail (Min) [-] [-] ₹[-]
Retail (Max) [-] [-] ₹[-]
S HNI (Min) [-] [-] ₹[-]
S HNI (Max) [-] [-] ₹[-]
B HNI (MIN) [-] [-] ₹[-]

Manipal Health Enterprises Limited IPO registrar

KFin Techologies Ltd
Phone Number 91 40 67162222/180 03094001
Email Id manipal.ipo@kfintech.com
Website www.kfintech.com

Manipal Health Enterprises Limited IPO Lead Manager

1. Kotak Mahindra Capital Company Limited

2. Axis Capital Limited

3. Goldman Sachs (India) Securities Private Limited

4. Jefferies India Private Limited

5. J.P. Morgan India Private Limited

6. UBS Securities India Private Limited

7. DBS Bank India Limited

Manipal Health Enterprises Limited Financial Information

March 31, 2025 March 31, 2024 March 31, 2023
Net Worth ₹5,847.31 Cr ₹4,015.51 Cr ₹3,242.12 Cr
Reserves and Surplus ₹5,770.25 Cr ₹3,939.88 Cr ₹3,166.49 Cr
Total Borrowing ₹4,766.81 Cr ₹3,943.99 Cr ₹2,149.69 Cr

Strength of Manipal Health Enterprises Limited

  • India's largest multispecialty hospital group by bed capacity with pan-India presence and leadership in our three key regions.
  • We are the only private hospital chain network in India with leadership in three metros (Bengaluru, Kolkata and Pune) with a balanced and diversified presence across metros and non-metros.
  • Widely recognized brand and network of choice for patients, doctors and healthcare professionals.
  • Advanced infrastructure and medical equipment, with a strong focus on clinical excellence.
  • Track record of delivering industry leading growth with strong profitability and efficiency metrics.
  • Repeatable playbook for integrating and scaling transformative acquisitions to improve access to quality healthcare.
  • Experienced leadership team with marquee institutional shareholder support.

Risks Involved

  • A substantial number of its hospitals are located in Karnataka. The company derived 49.55%, 51.55%, 59.98%, and 66.61% of the company's revenue from operations in the six months ended September 30, 2025 and in Fiscals 2025, 2024 and 2023, respectively, from its hospitals in Karnataka. Any loss of business or disruption in the operations of these hospitals or geopolitical or policy changes in Karnataka could have a material adverse effect on the company's business, financial condition, results of operations, cash flows and prospects.
  • The company primarily generate revenue by providing inpatient care at the company's hospitals. Any inability to maintain or improve its admissions and hospital occupancy rates could adversely affect the company's business, financial condition, results of operations, cash flows and prospects.
  • The company deriveds 64.08%, 62.56%, 61.55% and 60.25% of its gross inpatient revenue from cardiac sciences, oncology, neurosciences, gastro sciences, orthopaedics, and renal sciences ("CONGO-R") specialties in the six months ended September 30, 2025 and in Fiscals 2025, 2024 and 2023, respectively, and any negative changes in the demand for these specialties could adversely impact the company's business, results of operations and financial condition.
  • The company is exposed to legal claims and regulatory actions arising from the provision of healthcare services and may be subject to liabilities arising from operational and equipment-related risks, which could materially and adversely affect its reputation, financial position, and results of operations. Further, quarantines and sterilizations could limit the operations of hospitals and result in reputational damage.
  • The company may be subject to claims arising from alleged medical negligence by its doctors and other healthcare professionals, which could materially and adversely affect the company's reputation and business.
  • Acquisitions, strategic investments, partnerships or alliances may be difficult to identify, acquire and integrate, and may adversely affect its business, financial condition, results of operations, cash flows and prospects.
  • Any failures to maintain and enhance its brand and reputation, and any negative publicity and allegations in the media against the company, may adversely affect the level of trust in its services and market recognition, which could have an adverse impact on the company's business, financial condition, results of operations, cash flows and prospects.
  • The company is requireds to obtain, renew and maintain statutory and regulatory permits, licenses and accreditations and comply with prescribed quality standards. Any regulatory changes or violations of such rules and regulations, or failures to obtain or renew approvals, licenses, registrations and permits to operate our business or comply with prescribed quality standards in a timely manner, or at all, may adversely affect its business, financial condition, results of operations, cash flows and prospects.
  • The company may experience delays in construction or commencement of operations at new hospitals that the company builds, and the company may be unsuccessful in developing other facilities in the future, in a timely manner or at all, which may have an adverse effect on its growth, business, financial condition, results of operations, cash flows and prospects.
  • There are outstanding proceedings against the Company, Promoters, Directors, Subsidiaries, Key Managerial Personnel and Senior Management. An adverse outcome in any of these proceedings may adversely affect its business, reputation, brand, financial condition, results of operations, cash flows and prospects.
stock
Invest in IPOs with ease

Sign-in to invest with your demat account, or set up a new demat account for free

Explore Other IPOs

  • Current IPOs
  • Upcoming IPOs
  • Closed IPOs
  • IPO Performance
  • All
  • MainBoard
  • SME
RIYAASAT LIFESTYLE LIMITED IPO
icon
SME IPO
Early Access
Bidding Period
18th Jun 2026 - 6th Jun 2026
Price Range
₹100.0 - 106.0
IPO Size
₹30,00,00,000
Bidding Period
23rd Jun 2026 - 6th Jun 2026
Price Range
₹769.0 - 808.0
IPO Size
₹6,15,00,00,000
SHREEDHAR SPINNERS LIMITED IPO
icon
SME IPO
Early Access
Bidding Period
23rd Jun 2026 - 6th Jun 2026
Price Range
₹51.0 - 53.0
IPO Size
₹31,00,00,000
ADVIT JEWELS LIMITED IPO
icon
SME IPO
Early Access
Bidding Period
23rd Jun 2026 - 6th Jun 2026
Price Range
₹130.0 - 138.0
IPO Size
₹1,65,00,00,000
CSM TECHNOLOGIES LIMITED IPO
icon
SME IPO
Early Access
Bidding Period
24th Jun 2026 - 6th Jun 2026
Price Range
₹107.0 - 113.0
IPO Size
₹1,46,00,00,000
DHANWEL HYBRID SEEDS LIMITED IPO
icon
SME IPO
Early Access
Bidding Period
24th Jun 2026 - 6th Jun 2026
Price Range
₹95.0 - 99.0
IPO Size
₹27,00,00,000
Bidding Period
25th Jun 2026 - 6th Jun 2026
Price Range
₹94.0 - 99.0
IPO Size
₹48,00,00,000
  • All
  • MainBoard
  • SME
Bidding Period
24th Jun 2026 - 6th Jun 2026
Price Range
₹207.0 - 212.0
IPO Size
₹94,51,00,000
Crazy Snacks Limited IPO
icon
SME IPO
Early Access
Bidding Period
25th Jun 2026 - 6th Jun 2026
Price Range
₹39.0 - 42.0
IPO Size
₹31,47,00,000
Aastha Spintex Limited IPO
icon
SME IPO
Early Access
Bidding Period
29th Jun 2026 - 7th Jul 2026
Price Range
₹125.0 - 136.0
IPO Size
₹1,70,00,00,000
Bidding Period
29th Jun 2026 - 7th Jul 2026
Price Range
₹66.0 - 70.0
IPO Size
₹44,03,00,000
Twinkle Papers Limited IPO
icon
SME IPO
Early Access
Bidding Period
29th Jun 2026 - 7th Jul 2026
Price Range
₹64.0 - 69.0
IPO Size
₹27,52,00,000
Atharva PolyPlast Limited IPO
icon
SME IPO
Early Access
Bidding Period
30th Jun 2026 - 7th Jul 2026
Price Range
₹55.0 - 60.0
IPO Size
₹27,00,00,000
Kratikal Tech Limited IPO
icon
SME IPO
Early Access
Bidding Period
30th Jun 2026 - 7th Jul 2026
Price Range
₹128.0 - 135.0
IPO Size
₹37,34,00,000
Bidding Period
30th Jun 2026 - 7th Jul 2026
Price Range
₹80.0 - 84.0
IPO Size
₹27,22,00,000
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
AceVector Limited IPO
icon
SME IPO
Early Access
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Advanced SysTek Limited IPO
icon
SME IPO
Early Access
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Advanta Enterprises Limited IPO
icon
SME IPO
Early Access
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Agilus Diagnostics Limited IPO
icon
SME IPO
Early Access
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Airox Technologies Limited IPO
icon
SME IPO
Early Access
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Ajay Poly Limited IPO
icon
SME IPO
Early Access
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Allchem Lifescience Limited IPO
icon
SME IPO
Early Access
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
NO ACTIVE IPO HERE
  • All
  • MainBoard
  • SME
TURTLEMINT FINTECH SOLUTIONS LIMITED IPO
icon
Closing Today
SME IPO
Early Access
Bidding Period
19th Jun 2026 - 6th Jun 2026
Price Range
₹144.0 - 152.0
IPO Size
₹2,22,00,00,000
ANUBHAV PLAST LIMITED IPO
icon
Closing Today
SME IPO
Early Access
Bidding Period
19th Jun 2026 - 6th Jun 2026
Price Range
₹77.0 - 80.0
IPO Size
₹24,00,00,000
AVIENCE BIOMEDICALS LIMITED IPO
icon
SME IPO
Early Access
Bidding Period
18th Jun 2026 - 6th Jun 2026
Price Range
₹196.0 - 208.0
IPO Size
₹30,00,00,000
CLAY CRAFT INDIA LIMITED IPO
icon
SME IPO
Early Access
Bidding Period
17th Jun 2026 - 6th Jun 2026
Price Range
₹193.0 - 203.0
IPO Size
₹1,10,00,00,000
DIKSHA POLYMERS LIMITED IPO
icon
SME IPO
Early Access
Bidding Period
17th Jun 2026 - 6th Jun 2026
Price Range
₹112.0 - 112.0
IPO Size
₹18,00,00,000
Bidding Period
17th Jun 2026 - 6th Jun 2026
Price Range
₹21.0 - 23.0
IPO Size
₹89,00,00,000
LIOTECH INDUSTRIES LIMITED IPO
icon
SME IPO
Early Access
Bidding Period
17th Jun 2026 - 6th Jun 2026
Price Range
₹321.0 - 321.0
IPO Size
₹36,00,00,000
Bidding Period
12th Jun 2026 - 6th Jun 2026
Price Range
₹98.0 - 103.0
IPO Size
₹54,00,00,000
Bidding Period
11th Jun 2026 - 6th Jun 2026
Price Range
₹120.0 - 127.0
IPO Size
₹70,00,00,000
Bidding Period
10th Jun 2026 - 6th Jun 2026
Price Range
₹62.0 - 66.0
IPO Size
₹35,00,00,000
HEXAGON NUTRITION LIMITED IPO
icon
SME IPO
Early Access
Bidding Period
5th Jun 2026 - 6th Jun 2026
Price Range
₹42.0 - 45.0
IPO Size
₹1,39,00,00,000
GENXAI ANALYTICS LIMITED IPO
icon
SME IPO
Early Access
Bidding Period
5th Jun 2026 - 6th Jun 2026
Price Range
₹110.0 - 116.0
IPO Size
₹54,84,00,000
VAHH CHEMICALS LIMITED IPO
icon
SME IPO
Early Access
Bidding Period
4th Jun 2026 - 6th Jun 2026
Price Range
₹61.0 - 61.0
IPO Size
₹13,00,00,000
UHM VACATION LIMITED IPO
icon
SME IPO
Early Access
Bidding Period
4th Jun 2026 - 6th Jun 2026
Price Range
₹157.0 - 166.0
IPO Size
₹36,02,00,000
Bidding Period
3rd Jun 2026 - 6th Jun 2026
Price Range
₹182.0 - 192.0
IPO Size
₹6,31,00,00,000
MERRITRONIX LIMITED IPO
icon
SME IPO
Early Access
Bidding Period
1st Jun 2026 - 6th Jun 2026
Price Range
₹141.0 - 149.0
IPO Size
₹70,00,00,000
SMR JEWELS LIMITED IPO
icon
SME IPO
Early Access
Bidding Period
26th May 2026 - 6th Jun 2026
Price Range
₹125.0 - 128.0
IPO Size
₹12,54,00,000
AUREATE TRADDE LIMITED IPO
icon
SME IPO
Early Access
Bidding Period
29th May 2026 - 6th Jun 2026
Price Range
₹70.0 - 70.0
IPO Size
₹27,00,00,000
Bidding Period
26th May 2026 - 5th May 2026
Price Range
₹59.0 - 63.0
IPO Size
₹18,00,00,000
HARIKANTA OVERSEAS LIMITED IPO
icon
SME IPO
Early Access
Bidding Period
20th May 2026 - 5th May 2026
Price Range
₹86.0 - 91.0
IPO Size
₹24,00,00,000
  • All
  • MainBoard
  • SME
Issue Prize
103.00
Listing Day Close
147.30(42.72%)
Issue Prize
127.00
Listing Day Close
195.30(53.54%)
Issue Prize
66.00
Listing Day Close
62.70(-4.55%)
HEXAGON NUTRITION LIMITED IPO
icon
SME IPO
Early Access
Issue Prize
45.00
Listing Day Close
50.39(11.11%)
GENXAI ANALYTICS LIMITED IPO
icon
SME IPO
Early Access
Issue Prize
116.00
Listing Day Close
97.40(-16.38%)
VAHH CHEMICALS LIMITED IPO
icon
SME IPO
Early Access
Issue Prize
60.00
Listing Day Close
66.50(11.67%)
UHM VACATION LIMITED IPO
icon
SME IPO
Early Access
Issue Prize
166.00
Listing Day Close
126.20(-24.10%)
Issue Prize
192.00
Listing Day Close
247.90(29.17%)
MERRITRONIX LIMITED IPO
icon
SME IPO
Early Access
Issue Prize
149.00
Listing Day Close
297.25(99.33%)
SMR JEWELS LIMITED IPO
icon
SME IPO
Early Access
Issue Prize
128.00
Listing Day Close
103.05(-19.53%)
AUREATE TRADDE LIMITED IPO
icon
SME IPO
Early Access
Issue Prize
70.00
Listing Day Close
66.50(-4.29%)
Issue Prize
63.00
Listing Day Close
60.57(-3.17%)
HARIKANTA OVERSEAS LIMITED IPO
icon
SME IPO
Early Access
Issue Prize
91.00
Listing Day Close
75.77(-16.48%)
YAASHVI JEWELLERS LIMITED IPO
icon
SME IPO
Early Access
Issue Prize
83.00
Listing Day Close
87.05(4.82%)
M R MANIVENI FOODS LIMITED IPO
icon
SME IPO
Early Access
Issue Prize
52.00
Listing Day Close
41.13(-21.15%)
QLINE BIOTECH LIMITED IPO
icon
SME IPO
Early Access
Issue Prize
343.00
Listing Day Close
474.60(38.48%)
AUTOFURNISH LIMITED IPO
icon
SME IPO
Early Access
Issue Prize
41.00
Listing Day Close
45.15(9.76%)
Issue Prize
139.00
Listing Day Close
115.80(-16.55%)
Issue Prize
77.00
Listing Day Close
124.00(61.04%)
Issue Prize
63.00
Listing Day Close
72.75(15.87%)

Frequently Asked Questions

What is Manipal Health Enterprises Limited IPO?

Answer Field

Manipal Health Enterprises Limited IPO is a IPO of [-] equity shares of a face value of ₹[-] aggregating up to ₹[-] Crores. The issue is priced at ₹[-] to ₹[-] per share. The minimum order quantity is [-] Shares. The IPO opens on [-], and closes on [-]. KFin Techologies Ltd is the registrar for the IPO. The shares are proposed to be listed on .

When Manipal Health Enterprises Limited IPO will open?

Answer Field

The Manipal Health Enterprises Limited IPO opens on [-] and closes on [-].

What is the lot size of Manipal Health Enterprises Limited?

Answer Field

Manipal Health Enterprises Limited lot size is [-] shares, and the minimum amount required is ₹[-].

How to apply for Manipal Health Enterprises Limited IPO?

Answer Field

You can apply in Manipal Health Enterprises Limited IPO online using either UPI or ASBA as payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO application is offered by brokers who don't offer banking services. To apply for an IPO:

  • Login to Bajaj Broking account App/Website & click on IPO
  • Enter the number of lots and price at which you wish to apply.
  • Enter your UPI ID and click on submit. With this, your bid will be placed with the exchange.
  • You will receive a mandate notification to block funds in your UPI app.
  • Approve the mandate request on your UPI and funds will be blocked.

When is Manipal Health Enterprises Limited IPO allotment?

Answer Field

The finalization of Basis of Allotment for Manipal Health Enterprises Limited IPO will be done on [-], and the allotted shares will be credited to your demat account by [-].

When is Manipal Health Enterprises Limited IPO listing date?

Answer Field

The Manipal Health Enterprises Limited listing date is [-].

Who is the registrar of Manipal Health Enterprises Limited IPO?

Answer Field

The registrar of Manipal Health Enterprises Limited IPO is KFin Techologies Ltd

Which company is the book-running lead manager of the IPO?

Answer Field

Kotak Mahindra Capital Company Limited,Axis Capital Limited,Goldman Sachs (India) Securities Private Limited,Jefferies India Private Limited,J.P. Morgan India Private Limited,UBS Securities India Private Limited,DBS Bank India Limited will be the book-running lead manager of this IPO.

What is the fresh issue of Manipal Health Enterprises Limited IPO?

Answer Field

The fresh issue size is ₹[-] Crores equity shares.

What minimum lot size can retail subscribers subscribe to Manipal Health Enterprises Limited?

Answer Field

Retail investors can subscribe to a minimum of one lot, [-] shares and ₹[-] amount.

How can I approve the UPI mandate request for Manipal Health Enterprises Limited IPO?

Answer Field

To apply for Manipal Health Enterprises Limited IPO, you need to log in to your demat account to complete the bidding process. Then, approve the payment mandate on your UPI app.

What is the price range of Manipal Health Enterprises Limited?

Answer Field

The price of each Manipal Health Enterprises Limited share will be ranging in between ₹[-] to ₹[-] per share.

What is the cut-off time for the UPI mandate for Manipal Health Enterprises Limited IPO?

Answer Field

The cut-off time for the UPI mandate confirmation is 5:00 PM, [-].

No results found

banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|